Single Center, Prospective, Randomized, Controlled, Non-significant Risk
NCT03286166 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-12-12
Summary
A randomized controlled trial to evaluate the efficiency of serum tears made with Genius PRP for improving signs and symptoms in Dry Eye Disease (DED).
Single center, Prospective, Randomized, Controlled, Non-significant risk
Conditions
- Dry Eye
Sponsors & Collaborators
-
Toyos Clinic
lead OTHER
Eligibility
- Min Age
- 22 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-01
- Primary Completion
- 2022-10-31
- Completion
- 2022-10-31
Countries
- United States
Study Locations
More Related Trials
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Efficacy of Amniotic Membrane Extract Eye Drops in Dry Eye Treatment
NCT05169931 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02965846 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Lifitegrast 5% on Tear Film Markers
NCT03952481 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02815293 ·Status: TERMINATED ·Phase: PHASE3
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
NCT02600429 ·Status: TERMINATED ·Phase: PHASE3
-
Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.
NCT03691636 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01960010 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
NCT02284516 ·Status: COMPLETED ·Phase: PHASE3
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
NCT02597803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
NCT01743729 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
NCT06244316 ·Status: COMPLETED ·Phase: PHASE2
-
Study of VVN001 Ophthalmic Solution in Dry Eye Disease
NCT04556838 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
NCT03878628 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Management of Signs and Symptoms Associated With Dry Eye Disease
NCT04015219 ·Status: TERMINATED ·Phase: NA
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers
NCT03431272 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
NCT05841043 ·Status: COMPLETED ·Phase: PHASE3
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
NCT02257957 ·Status: COMPLETED ·Phase: PHASE3
-
Allogeneic Versus Autologous Serum Eye Drops
NCT03085290 ·Status: COMPLETED ·Phase: NA